Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.

JAMA - 23 Feb 2005

Claus Elizabeth B, Petruzella Stacey, Matloff Ellen, Carter Darryl

Abstract excerpt

CONTEXT: The distribution of BRCA1 and BRCA2 mutations in women diagnosed with noninvasive breast carcinoma is unknown. OBJECTIVE: To estimate the BRCA1 and BRCA2 mutation prevalence in women with ductal carcinoma in situ (DCIS), unselected for age, family history, or ethnicity. DESIGN, SETTING, AND PARTICIPANTS: The data were 369 DCIS cases diagnosed among female residents aged 20 to 79 years from the state of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 gene

Share to BRCA2 gene

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mutation

Source

Identifiers

PMID: 15728167
DOI: 10.1001/jama.293.8.964

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.PMID 15728167Read ↗

Ductal carcinoma in situ in BRCA mutation carriers.Semantic proximity Read ↗

Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.Semantic proximity Read ↗

BRCA mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.Semantic proximity Read ↗

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Genetic risk variants associated with in situ breast cancer.Semantic proximity Read ↗

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancerSemantic proximity Read ↗

The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.Semantic proximity Read ↗

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.Semantic proximity Read ↗

Genetic predisposition to ductal carcinoma in situ of the breast.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.